• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

FLUPHENAZINE Drug Record

  • Summary
  • Interactions
  • Claims
  • FLUPHENAZINE chembl:CHEMBL726 Approved

    Alternate Names:

    NSC-62323
    PERMITIL
    FLUPHENAZINE
    PROLIXIN
    FLUORPHENAZINE
    FLUPHENAZINUM
    4-(3-(2-TRIFLUOROMETHYL-10-PHENOTHIAZYL)-PROPYL)-1-PIPERAZINEETHANOL
    4-(3-(2-(TRIFLUOROMETHYL)-10H-PHENOTHIAZIN-10-YL)PROPYL)-1-PIPERAZINEETHANOL
    FLUOROPHENAZINE
    TRIFLUMETHAZINE
    PROLIXIN®
    4-(3-(-TRIFLUOROMETHYL-10-PHENOTHIAZYL)-PROPYL)-1-PIPERAZINEETHANOL
    10-(3'-(4''-(BETA-HYDROXYETHYL)-1''-PIPERAZINYL)-PROPYL)-3-TRIFLUOROMETHYLPHENOTHIAZINE
    10-(3-(2-HYDROXYETHYL)PIPERAZINOPROPYL)-2-(TRIFLUOROMETHYL)PHENOTHIAZINE
    2-(TRIFLUOROMETHYL)-10-(3-(1-(BETA-HYDROXYETHYL)-4-PIPERAZINYL)PROPYL)PHENOTHIAZINE
    FLUPHENAZIN
    FLUFENAZINA
    1-(2-HYDROXYETHYL)-4-(3-(TRIFLUOROMETHYL-10-PHENOTHIAZINYL)PROPYL)-PIPERAZINE
    2-(4-(3-[2-(TRIFLUOROMETHYL)-10H-PHENOTHIAZIN-10-YL]PROPYL)-1-PIPERAZINYL)ETHANOL
    FLUPHÉNAZINE
    FLUORFENAZINE
    chemidplus:69-23-8
    drugbank:00623
    pubchem.compound:3372
    rxcui:4496
    chembl:CHEMBL726

    Drug Info:

    FDA Approval 1959
    Drug Class small molecule
    Drug Indications Antipsychotic Agents
    Year of Approval 1959
    Drug Class antipsychotic agents
    (2 More Sources)

    Publications:

    Seeman, 2002, Atypical antipsychotics: mechanism of action., Can J Psychiatry
    Van Kampen et al., 2000, Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia., Neuroscience
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Cai et al., 1999, Inverse agonist properties of dopaminergic antagonists at the D(1A) dopamine receptor: uncoupling of the D(1A) dopamine receptor from G(s) protein., Mol. Pharmacol.
    Tay JK et al., 2007, Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia., Prog Neuropsychopharmacol Biol Psychiatry
    Høyberg et al., 1993, Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations., Acta Psychiatr Scand
    Qin et al., 1994, Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra., Eur. J. Pharmacol.
  • FLUPHENAZINE   DRD1

    Interaction Score: 0.28

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    11873706 11113312 11752352 10531405


    Sources:
    DTC TdgClinicalTrial TEND

  • FLUPHENAZINE   DRD2

    Interaction Score: 0.22

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    11873706 7508675 11752352 7828655


    Sources:
    TdgClinicalTrial TEND

  • FLUPHENAZINE   HTR1B

    Interaction Score: 0.19

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • FLUPHENAZINE   CBX1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FLUPHENAZINE   CYP1A2

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17611010


    Sources:
    DTC PharmGKB

  • FLUPHENAZINE   USP1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FLUPHENAZINE   ABCB1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • FLUPHENAZINE   CYP2D6

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC PharmGKB

  • FLUPHENAZINE   TP53

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FLUPHENAZINE   EHMT2

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: FLUPHENAZINE

    • Version: 01-August-2011

    Alternate Names:
    FLUPHENAZINE Primary Drug Name

    Drug Info:
    Drug Class antipsychotic agents
    Year of Approval 1959

    Publications:

  • TdgClinicalTrial: FLUPHENAZINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antipsychotic Agents
    Drug Class small molecule
    FDA Approval 1959

    Publications:

  • PharmGKB: fluphenazine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Tay JK et al., 2007, Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia., Prog Neuropsychopharmacol Biol Psychiatry

  • DTC: FLUPHENAZINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL726 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Fluphenazine

    • Version: 2020.06.01

    Alternate Names:
    D0P5SA TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL726

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21